

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | defense response to fungus (GO:0050832) | 9.03374587 |
| 2 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 7.60459169 |
| 3 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 7.60459169 |
| 4 | response to fungus (GO:0009620) | 7.24187364 |
| 5 | sequestering of metal ion (GO:0051238) | 7.03134660 |
| 6 | response to peptidoglycan (GO:0032494) | 6.73427422 |
| 7 | neutrophil mediated immunity (GO:0002446) | 6.59916026 |
| 8 | cellular extravasation (GO:0045123) | 6.40219545 |
| 9 | respiratory burst (GO:0045730) | 5.97109373 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 5.90068068 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.82060390 |
| 12 | negative regulation of cell killing (GO:0031342) | 5.82060390 |
| 13 | disruption of cells of other organism (GO:0044364) | 5.68076791 |
| 14 | killing of cells of other organism (GO:0031640) | 5.68076791 |
| 15 | neutrophil activation (GO:0042119) | 5.40181081 |
| 16 | myeloid leukocyte mediated immunity (GO:0002444) | 5.18681125 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.07846564 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.07470346 |
| 19 | chronic inflammatory response (GO:0002544) | 4.96872168 |
| 20 | neutrophil chemotaxis (GO:0030593) | 4.92761616 |
| 21 | granulocyte activation (GO:0036230) | 4.91398665 |
| 22 | positive regulation of mast cell activation (GO:0033005) | 4.91165561 |
| 23 | macrophage differentiation (GO:0030225) | 4.90826785 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.82069596 |
| 25 | neutrophil migration (GO:1990266) | 4.79168701 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.62655989 |
| 27 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.56418708 |
| 28 | negative regulation of phagocytosis (GO:0050765) | 4.49754627 |
| 29 | microglial cell activation (GO:0001774) | 4.28102231 |
| 30 | reactive oxygen species biosynthetic process (GO:1903409) | 4.24660643 |
| 31 | regulation of mast cell degranulation (GO:0043304) | 4.23194738 |
| 32 | granulocyte migration (GO:0097530) | 4.22949250 |
| 33 | regulation of mast cell activation (GO:0033003) | 4.20640460 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.20101557 |
| 35 | positive regulation of mast cell degranulation (GO:0043306) | 4.16665826 |
| 36 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.16665826 |
| 37 | granulocyte chemotaxis (GO:0071621) | 4.13889012 |
| 38 | response to host immune response (GO:0052572) | 4.12591009 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.12591009 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 4.08869141 |
| 41 | detection of external biotic stimulus (GO:0098581) | 4.07407092 |
| 42 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.07303658 |
| 43 | regulation of growth of symbiont in host (GO:0044126) | 4.07303658 |
| 44 | negative regulation of growth of symbiont in host (GO:0044130) | 4.07303658 |
| 45 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.07303658 |
| 46 | leukocyte cell-cell adhesion (GO:0007159) | 4.01635811 |
| 47 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.01597981 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.97174537 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.92054846 |
| 50 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.91222537 |
| 51 | superoxide anion generation (GO:0042554) | 3.91157695 |
| 52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.90753404 |
| 53 | detection of bacterium (GO:0016045) | 3.83942597 |
| 54 | response to host (GO:0075136) | 3.82859427 |
| 55 | response to host defenses (GO:0052200) | 3.82859427 |
| 56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.82859427 |
| 57 | detection of other organism (GO:0098543) | 3.78524471 |
| 58 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.72103724 |
| 59 | macrophage activation (GO:0042116) | 3.69392715 |
| 60 | detection of biotic stimulus (GO:0009595) | 3.69119350 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.66496156 |
| 62 | pentose-phosphate shunt (GO:0006098) | 3.65644781 |
| 63 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.63209082 |
| 64 | leukotriene metabolic process (GO:0006691) | 3.60848172 |
| 65 | leukocyte mediated cytotoxicity (GO:0001909) | 3.57934578 |
| 66 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.55737293 |
| 67 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.54227667 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.50400554 |
| 69 | B cell mediated immunity (GO:0019724) | 3.50225359 |
| 70 | cell killing (GO:0001906) | 3.49747737 |
| 71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.48671349 |
| 72 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.47995489 |
| 73 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.46600048 |
| 74 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.46312746 |
| 75 | negative regulation of interleukin-6 production (GO:0032715) | 3.43207427 |
| 76 | phagosome maturation (GO:0090382) | 3.43172581 |
| 77 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.41531709 |
| 78 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.41531709 |
| 79 | modulation by symbiont of host immune response (GO:0052553) | 3.41531709 |
| 80 | positive regulation by symbiont of host defense response (GO:0052509) | 3.41531709 |
| 81 | modulation by symbiont of host defense response (GO:0052031) | 3.41531709 |
| 82 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.41531709 |
| 83 | response to muramyl dipeptide (GO:0032495) | 3.40431673 |
| 84 | * regulation of leukocyte degranulation (GO:0043300) | 3.40077213 |
| 85 | B cell receptor signaling pathway (GO:0050853) | 3.38407674 |
| 86 | activated T cell proliferation (GO:0050798) | 3.37335647 |
| 87 | positive regulation of antigen processing and presentation (GO:0002579) | 3.34103673 |
| 88 | leukotriene biosynthetic process (GO:0019370) | 3.33210305 |
| 89 | detection of molecule of bacterial origin (GO:0032490) | 3.33049605 |
| 90 | defense response to protozoan (GO:0042832) | 3.30996577 |
| 91 | regulation of B cell differentiation (GO:0045577) | 3.30421537 |
| 92 | mast cell activation (GO:0045576) | 3.27014280 |
| 93 | negative thymic T cell selection (GO:0045060) | 3.22920517 |
| 94 | NADPH regeneration (GO:0006740) | 3.21953249 |
| 95 | myeloid leukocyte migration (GO:0097529) | 3.20795483 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.19813532 |
| 97 | negative regulation of interleukin-12 production (GO:0032695) | 3.18987421 |
| 98 | response to interleukin-15 (GO:0070672) | 3.18761202 |
| 99 | dendritic cell migration (GO:0036336) | 3.17456947 |
| 100 | regulation of antigen processing and presentation (GO:0002577) | 3.15898862 |
| 101 | positive regulation of leukocyte degranulation (GO:0043302) | 3.15777966 |
| 102 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.15669463 |
| 103 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.14908538 |
| 104 | positive thymic T cell selection (GO:0045059) | 3.13599021 |
| 105 | response to protozoan (GO:0001562) | 3.11542335 |
| 106 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.09837887 |
| 107 | immunoglobulin mediated immune response (GO:0016064) | 3.08658010 |
| 108 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.08088572 |
| 109 | adaptation of signaling pathway (GO:0023058) | 3.07849135 |
| 110 | negative T cell selection (GO:0043383) | 3.07387699 |
| 111 | tolerance induction (GO:0002507) | 3.06827718 |
| 112 | positive regulation of lamellipodium assembly (GO:0010592) | 3.06465200 |
| 113 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05641728 |
| 114 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.05439158 |
| 115 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.05439158 |
| 116 | regulation of tolerance induction (GO:0002643) | 3.05306499 |
| 117 | leukocyte degranulation (GO:0043299) | 3.03670429 |
| 118 | positive regulation of granulocyte differentiation (GO:0030854) | 3.03186094 |
| 119 | * regulation of regulated secretory pathway (GO:1903305) | 3.01723468 |
| 120 | negative regulation of innate immune response (GO:0045824) | 2.99492968 |
| 121 | positive regulation of B cell differentiation (GO:0045579) | 2.97051195 |
| 122 | innate immune response in mucosa (GO:0002227) | 2.96707092 |
| 123 | myeloid cell activation involved in immune response (GO:0002275) | 2.93256241 |
| 124 | leukocyte chemotaxis (GO:0030595) | 2.92808400 |
| 125 | actin nucleation (GO:0045010) | 2.92652414 |
| 126 | negative regulation of interleukin-10 production (GO:0032693) | 2.92013937 |
| 127 | cellular response to interleukin-15 (GO:0071350) | 2.91962965 |
| 128 | myeloid leukocyte activation (GO:0002274) | 2.91616937 |
| 129 | macrophage activation involved in immune response (GO:0002281) | 2.91562670 |
| 130 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.91139850 |
| 131 | dendritic cell chemotaxis (GO:0002407) | 2.89941790 |
| 132 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.87314032 |
| 133 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.86386436 |
| 134 | antimicrobial humoral response (GO:0019730) | 2.86204034 |
| 135 | defense response to bacterium (GO:0042742) | 2.86156106 |
| 136 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.86081320 |
| 137 | T cell migration (GO:0072678) | 2.85402937 |
| 138 | negative regulation of interleukin-8 production (GO:0032717) | 2.83434131 |
| 139 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.83356839 |
| 140 | negative regulation of interleukin-1 production (GO:0032692) | 2.82732102 |
| 141 | negative regulation of granulocyte differentiation (GO:0030853) | 2.82363048 |
| 142 | defense response to Gram-positive bacterium (GO:0050830) | 2.82233063 |
| 143 | mucosal immune response (GO:0002385) | 2.81480173 |
| 144 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.81473033 |
| 145 | antibacterial humoral response (GO:0019731) | 2.81094423 |
| 146 | positive regulation of osteoblast proliferation (GO:0033690) | 2.80587691 |
| 147 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.80157650 |
| 148 | leukocyte aggregation (GO:0070486) | 10.6142897 |
| 149 | leukocyte migration involved in inflammatory response (GO:0002523) | 10.0159981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.57006259 |
| 2 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.43356738 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.32276691 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.30435105 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.13173898 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.04865242 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.46928144 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.30249352 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.23142731 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.20988833 |
| 11 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 3.20239878 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15274880 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.07854579 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.88824323 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.76997691 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.70607994 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.68912408 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.61670577 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60794961 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.55433378 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.54098679 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.39635283 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.38104712 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.35124146 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.34488511 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33805753 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.29872599 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 2.25576705 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.25539291 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.24247639 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.17350178 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10350909 |
| 33 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03873584 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02614442 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 2.01841754 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.98396676 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.93213675 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89494271 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84598496 |
| 40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.84013603 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.83449985 |
| 42 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81557573 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79697900 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78503951 |
| 45 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.77130104 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72957721 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65198900 |
| 48 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62336892 |
| 49 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57309998 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53899751 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51386050 |
| 52 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49736879 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48515989 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47824315 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47081961 |
| 56 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45802661 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42977381 |
| 58 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42804334 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41686157 |
| 60 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38700830 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35693478 |
| 62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35232155 |
| 63 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.33972451 |
| 64 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33373107 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33365925 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33336797 |
| 67 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.32881459 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.32555650 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31464415 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28507851 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27098601 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25884806 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25844723 |
| 74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21451749 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21033723 |
| 76 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20662157 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19790802 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17841489 |
| 79 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17095255 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.16333416 |
| 81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16022081 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15836555 |
| 83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14535366 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11639670 |
| 85 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10541381 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09334927 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08597649 |
| 88 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07193156 |
| 89 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06646364 |
| 90 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.06454097 |
| 91 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02819187 |
| 92 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01263397 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99800534 |
| 94 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.98498517 |
| 95 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97891976 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97780253 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 0.96955675 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96910583 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95477464 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95206909 |
| 101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94365310 |
| 102 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92107826 |
| 103 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91415429 |
| 104 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.91164854 |
| 105 | P68_20966046_ChIP-Seq_HELA_Human | 0.89554566 |
| 106 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89385514 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89199429 |
| 108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88320253 |
| 109 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.88082135 |
| 110 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85279315 |
| 111 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81693645 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79912349 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78821599 |
| 114 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78731611 |
| 115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78460521 |
| 116 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.78306557 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78187098 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78010553 |
| 119 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.76324771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.38992888 |
| 2 | MP0003436_decreased_susceptibility_to | 4.73338863 |
| 3 | MP0009785_altered_susceptibility_to | 3.56420457 |
| 4 | MP0009278_abnormal_bone_marrow | 3.51226339 |
| 5 | MP0003183_abnormal_peptide_metabolism | 3.44570756 |
| 6 | * MP0002419_abnormal_innate_immunity | 3.19679605 |
| 7 | MP0005025_abnormal_response_to | 2.57514140 |
| 8 | MP0001533_abnormal_skeleton_physiology | 2.41186024 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.39458457 |
| 10 | MP0002405_respiratory_system_inflammati | 2.35090035 |
| 11 | MP0001853_heart_inflammation | 2.34464930 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.34445383 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.30678944 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 2.23782299 |
| 15 | MP0001545_abnormal_hematopoietic_system | 2.23782299 |
| 16 | MP0000343_altered_response_to | 2.23655687 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.22514980 |
| 18 | MP0001800_abnormal_humoral_immune | 2.21321407 |
| 19 | MP0000685_abnormal_immune_system | 2.18129124 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.16101854 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.15048476 |
| 22 | * MP0001819_abnormal_immune_cell | 2.13838011 |
| 23 | MP0003724_increased_susceptibility_to | 2.13480583 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.08057104 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 2.05875596 |
| 26 | MP0005387_immune_system_phenotype | 2.05826109 |
| 27 | MP0001790_abnormal_immune_system | 2.05826109 |
| 28 | MP0000569_abnormal_digit_pigmentation | 2.05462633 |
| 29 | MP0002723_abnormal_immune_serum | 2.02513497 |
| 30 | MP0000858_altered_metastatic_potential | 1.99064898 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.93934101 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 1.91908391 |
| 33 | MP0001851_eye_inflammation | 1.89233209 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.86032134 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.83168689 |
| 36 | MP0002398_abnormal_bone_marrow | 1.79654663 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.76074400 |
| 38 | MP0002837_dystrophic_cardiac_calcinosis | 1.75385140 |
| 39 | MP0000716_abnormal_immune_system | 1.72019037 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.68235932 |
| 41 | MP0002132_abnormal_respiratory_system | 1.65070128 |
| 42 | MP0004883_abnormal_blood_vessel | 1.63301285 |
| 43 | MP0005167_abnormal_blood-brain_barrier | 1.59990703 |
| 44 | MP0005671_abnormal_response_to | 1.58616478 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.57029824 |
| 46 | MP0003075_altered_response_to | 1.54038358 |
| 47 | MP0005076_abnormal_cell_differentiation | 1.53674197 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.51097289 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.50231765 |
| 50 | MP0003448_altered_tumor_morphology | 1.48706222 |
| 51 | MP0002933_joint_inflammation | 1.45698190 |
| 52 | MP0002429_abnormal_blood_cell | 1.45443997 |
| 53 | MP0002722_abnormal_immune_system | 1.43441234 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.43423021 |
| 55 | MP0009764_decreased_sensitivity_to | 1.39364889 |
| 56 | MP0005075_abnormal_melanosome_morpholog | 1.39279049 |
| 57 | MP0008260_abnormal_autophagy | 1.38617897 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.35681226 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.35348492 |
| 60 | MP0004947_skin_inflammation | 1.32497966 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.30797246 |
| 62 | MP0001873_stomach_inflammation | 1.29376823 |
| 63 | MP0003828_pulmonary_edema | 1.24797792 |
| 64 | MP0005023_abnormal_wound_healing | 1.23202093 |
| 65 | MP0008469_abnormal_protein_level | 1.21836075 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.21459245 |
| 67 | MP0004510_myositis | 1.20398049 |
| 68 | MP0005164_abnormal_response_to | 1.19832471 |
| 69 | MP0002006_tumorigenesis | 1.19369634 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.19233431 |
| 71 | MP0010307_abnormal_tumor_latency | 1.14439819 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 1.11401068 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.11335539 |
| 74 | MP0000015_abnormal_ear_pigmentation | 1.10679727 |
| 75 | MP0004381_abnormal_hair_follicle | 1.08818307 |
| 76 | MP0003763_abnormal_thymus_physiology | 1.04560265 |
| 77 | MP0005390_skeleton_phenotype | 0.99279788 |
| 78 | MP0000490_abnormal_crypts_of | 0.95519763 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 0.94242141 |
| 80 | MP0002009_preneoplasia | 0.90771091 |
| 81 | MP0002928_abnormal_bile_duct | 0.90164861 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 0.89213451 |
| 83 | MP0009763_increased_sensitivity_to | 0.84796585 |
| 84 | MP0001663_abnormal_digestive_system | 0.83588310 |
| 85 | MP0003279_aneurysm | 0.83148536 |
| 86 | MP0000249_abnormal_blood_vessel | 0.83085072 |
| 87 | MP0005310_abnormal_salivary_gland | 0.82530497 |
| 88 | MP0003866_abnormal_defecation | 0.77956879 |
| 89 | MP0005166_decreased_susceptibility_to | 0.76684346 |
| 90 | MP0001958_emphysema | 0.76031141 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.75906508 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.74714650 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.74307191 |
| 94 | MP0003878_abnormal_ear_physiology | 0.74307191 |
| 95 | MP0003690_abnormal_glial_cell | 0.72845370 |
| 96 | MP0005083_abnormal_biliary_tract | 0.68809844 |
| 97 | MP0003638_abnormal_response/metabolism_ | 0.68436918 |
| 98 | MP0002877_abnormal_melanocyte_morpholog | 0.67286673 |
| 99 | MP0000604_amyloidosis | 0.67249654 |
| 100 | MP0009840_abnormal_foam_cell | 0.67087196 |
| 101 | MP0008057_abnormal_DNA_replication | 0.66570396 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.66397923 |
| 103 | MP0004264_abnormal_extraembryonic_tissu | 0.65994066 |
| 104 | MP0002095_abnormal_skin_pigmentation | 0.65615561 |
| 105 | MP0003693_abnormal_embryo_hatching | 0.65350736 |
| 106 | MP0003795_abnormal_bone_structure | 0.65058091 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.64338868 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.63438671 |
| 109 | MP0006082_CNS_inflammation | 0.62161624 |
| 110 | MP0008004_abnormal_stomach_pH | 0.61735638 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.60913288 |
| 112 | MP0004130_abnormal_muscle_cell | 0.59484274 |
| 113 | MP0005535_abnormal_body_temperature | 0.59351377 |
| 114 | MP0002133_abnormal_respiratory_system | 0.57669974 |
| 115 | MP0005388_respiratory_system_phenotype | 0.57669974 |
| 116 | MP0000609_abnormal_liver_physiology | 0.54160376 |
| 117 | MP0002998_abnormal_bone_remodeling | 0.53706255 |
| 118 | MP0003111_abnormal_nucleus_morphology | 0.52207167 |
| 119 | MP0008873_increased_physiological_sensi | 0.51327442 |
| 120 | MP0003045_fibrosis | 0.51234907 |
| 121 | MP0005381_digestive/alimentary_phenotyp | 0.47310876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 8.83067332 |
| 2 | Recurrent abscess formation (HP:0002722) | 8.49311464 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.76462683 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 7.60200090 |
| 5 | Chronic obstructive pulmonary disease (HP:0006510) | 5.78442742 |
| 6 | Obstructive lung disease (HP:0006536) | 5.78442742 |
| 7 | Gingivitis (HP:0000230) | 5.22255272 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.21848824 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 5.19580842 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.84196991 |
| 11 | Recurrent skin infections (HP:0001581) | 4.63525535 |
| 12 | Myositis (HP:0100614) | 4.50483579 |
| 13 | Stomatitis (HP:0010280) | 4.38566343 |
| 14 | Cellulitis (HP:0100658) | 4.15807484 |
| 15 | Urticaria (HP:0001025) | 4.07611192 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 4.00709767 |
| 17 | Meningitis (HP:0001287) | 3.90230481 |
| 18 | Orchitis (HP:0100796) | 3.80210537 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.51781123 |
| 20 | Periodontitis (HP:0000704) | 3.40123458 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.40028268 |
| 22 | Optic neuritis (HP:0100653) | 3.40028268 |
| 23 | IgM deficiency (HP:0002850) | 3.39710226 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.06892444 |
| 25 | Episodic fever (HP:0001954) | 3.05383057 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.00699651 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.00699651 |
| 28 | Agammaglobulinemia (HP:0004432) | 2.99895466 |
| 29 | Keratoconjunctivitis sicca (HP:0001097) | 2.94188204 |
| 30 | Osteomyelitis (HP:0002754) | 2.90142654 |
| 31 | Recurrent viral infections (HP:0004429) | 2.80009415 |
| 32 | Vasculitis (HP:0002633) | 2.70572356 |
| 33 | Abnormality of T cells (HP:0002843) | 2.68606753 |
| 34 | Abnormal platelet volume (HP:0011876) | 2.67448566 |
| 35 | Leukocytosis (HP:0001974) | 2.67119116 |
| 36 | Increased IgM level (HP:0003496) | 2.65833645 |
| 37 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.65510396 |
| 38 | Hemoptysis (HP:0002105) | 2.63817933 |
| 39 | Keratoconjunctivitis (HP:0001096) | 2.63806355 |
| 40 | Sepsis (HP:0100806) | 2.60672757 |
| 41 | Amyloidosis (HP:0011034) | 2.59567558 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.58422712 |
| 43 | Epistaxis (HP:0000421) | 2.57973458 |
| 44 | Microcytic anemia (HP:0001935) | 2.57919138 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.57665044 |
| 46 | Papilledema (HP:0001085) | 2.53452874 |
| 47 | Anorexia (HP:0002039) | 2.53227874 |
| 48 | Recurrent pneumonia (HP:0006532) | 2.52134418 |
| 49 | Hypergammaglobulinemia (HP:0010702) | 2.50191179 |
| 50 | Chest pain (HP:0100749) | 2.50128212 |
| 51 | Gingival bleeding (HP:0000225) | 2.49944652 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.49293656 |
| 53 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47686830 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47686830 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47686830 |
| 56 | Arterial thrombosis (HP:0004420) | 2.46999876 |
| 57 | Pustule (HP:0200039) | 2.43118734 |
| 58 | Thyroiditis (HP:0100646) | 2.41867677 |
| 59 | Abnormality of iron homeostasis (HP:0011031) | 2.41352436 |
| 60 | Absent frontal sinuses (HP:0002688) | 2.41086306 |
| 61 | Increased IgE level (HP:0003212) | 2.40236481 |
| 62 | Eosinophilia (HP:0001880) | 2.37866476 |
| 63 | Increased serum ferritin (HP:0003281) | 2.36920120 |
| 64 | Skin ulcer (HP:0200042) | 2.36639055 |
| 65 | Increased density of long bones (HP:0006392) | 2.36059599 |
| 66 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.35446545 |
| 67 | Petechiae (HP:0000967) | 2.35395695 |
| 68 | Thickened calvaria (HP:0002684) | 2.34078935 |
| 69 | Hepatosplenomegaly (HP:0001433) | 2.32719829 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.30662441 |
| 71 | Abnormality of T cell number (HP:0011839) | 2.28892664 |
| 72 | Cheilitis (HP:0100825) | 2.26588545 |
| 73 | Interstitial pulmonary disease (HP:0006530) | 2.23609102 |
| 74 | Vacuolated lymphocytes (HP:0001922) | 2.20352662 |
| 75 | Pulmonary embolism (HP:0002204) | 2.18453909 |
| 76 | T lymphocytopenia (HP:0005403) | 2.18150517 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.15650521 |
| 78 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.15531368 |
| 79 | Gastrointestinal inflammation (HP:0004386) | 2.14207533 |
| 80 | Granulocytopenia (HP:0001913) | 2.14136994 |
| 81 | Colitis (HP:0002583) | 2.12970933 |
| 82 | Impaired platelet aggregation (HP:0003540) | 2.11251153 |
| 83 | Abnormal platelet function (HP:0011869) | 2.11251153 |
| 84 | Purpura (HP:0000979) | 2.11001869 |
| 85 | Increased mean platelet volume (HP:0011877) | 2.07743741 |
| 86 | Systemic lupus erythematosus (HP:0002725) | 2.07126095 |
| 87 | Encephalitis (HP:0002383) | 2.05945848 |
| 88 | Skin rash (HP:0000988) | 2.05708427 |
| 89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03990549 |
| 90 | Vertigo (HP:0002321) | 2.02507097 |
| 91 | Recurrent lower respiratory tract infections (HP:0002783) | 2.02475506 |
| 92 | Abnormality of eosinophils (HP:0001879) | 2.02433331 |
| 93 | Peritonitis (HP:0002586) | 1.99639165 |
| 94 | Thoracic kyphosis (HP:0002942) | 1.99635753 |
| 95 | Gastrointestinal infarctions (HP:0005244) | 1.99557350 |
| 96 | Menorrhagia (HP:0000132) | 1.96371599 |
| 97 | Abnormality of B cell number (HP:0010975) | 1.94042696 |
| 98 | B lymphocytopenia (HP:0010976) | 1.94042696 |
| 99 | Autoimmune thrombocytopenia (HP:0001973) | 1.93851508 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 1.90463505 |
| 101 | Loss of speech (HP:0002371) | 1.88496860 |
| 102 | Polyneuropathy (HP:0001271) | 1.88158474 |
| 103 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87898695 |
| 104 | Spinal cord lesions (HP:0100561) | 1.85034422 |
| 105 | Syringomyelia (HP:0003396) | 1.85034422 |
| 106 | Abnormality of the thoracic spine (HP:0100711) | 1.84881106 |
| 107 | Acute hepatic failure (HP:0006554) | 1.84727659 |
| 108 | Viral hepatitis (HP:0006562) | 1.83524342 |
| 109 | Abnormality of T cell physiology (HP:0011840) | 1.82185521 |
| 110 | Gangrene (HP:0100758) | 1.81812667 |
| 111 | Chronic otitis media (HP:0000389) | 1.81097889 |
| 112 | Papilloma (HP:0012740) | 1.79382964 |
| 113 | Verrucae (HP:0200043) | 1.79382964 |
| 114 | Persistence of primary teeth (HP:0006335) | 1.79327090 |
| 115 | Abnormality of the pleura (HP:0002103) | 1.78714894 |
| 116 | Increased cerebral lipofuscin (HP:0011813) | 1.77980500 |
| 117 | Thrombocytosis (HP:0001894) | 1.77718973 |
| 118 | Abnormal foot bone ossification (HP:0010675) | 1.76522983 |
| 119 | Hypermelanotic macule (HP:0001034) | 1.76091584 |
| 120 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.74892183 |
| 121 | Lymphopenia (HP:0001888) | 1.74665759 |
| 122 | Dysostosis multiplex (HP:0000943) | 1.73429523 |
| 123 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.72483040 |
| 124 | Hypochromic anemia (HP:0001931) | 1.70981189 |
| 125 | Cutaneous photosensitivity (HP:0000992) | 1.68081341 |
| 126 | Abnormality of the prostate (HP:0008775) | 1.67753093 |
| 127 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.66723167 |
| 128 | Myelodysplasia (HP:0002863) | 1.66654828 |
| 129 | Abnormality of the endocardium (HP:0004306) | 1.65934515 |
| 130 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.64865892 |
| 131 | Spondylolisthesis (HP:0003302) | 1.63943951 |
| 132 | Agnosia (HP:0010524) | 1.63228500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 4.88255341 |
| 2 | EPHB1 | 3.88754488 |
| 3 | MAP4K1 | 2.89065726 |
| 4 | FES | 2.76033296 |
| 5 | RIPK4 | 2.60550188 |
| 6 | GRK6 | 2.53408742 |
| 7 | BTK | 2.49232894 |
| 8 | CSK | 2.48506153 |
| 9 | ERN1 | 2.42921345 |
| 10 | BLK | 2.33537076 |
| 11 | TXK | 2.29457811 |
| 12 | STK10 | 2.23675057 |
| 13 | TRPM7 | 2.21292717 |
| 14 | MAP2K3 | 2.13023175 |
| 15 | TAOK3 | 2.08788097 |
| 16 | CLK1 | 2.05145690 |
| 17 | HCK | 1.99262124 |
| 18 | TESK2 | 1.83033211 |
| 19 | TEC | 1.82051373 |
| 20 | TYK2 | 1.80342781 |
| 21 | TTN | 1.78584782 |
| 22 | FGR | 1.78314671 |
| 23 | CDK12 | 1.74948697 |
| 24 | IRAK3 | 1.71707008 |
| 25 | ZAP70 | 1.62816628 |
| 26 | PRPF4B | 1.52202806 |
| 27 | BCKDK | 1.50150941 |
| 28 | PAK4 | 1.40776237 |
| 29 | TRIB3 | 1.34863167 |
| 30 | PTK6 | 1.32322837 |
| 31 | LRRK2 | 1.31262629 |
| 32 | ERBB3 | 1.30303926 |
| 33 | MAP3K9 | 1.30117342 |
| 34 | SYK | 1.27270673 |
| 35 | MAP3K14 | 1.21000978 |
| 36 | CDK19 | 1.18158412 |
| 37 | ITK | 1.15306961 |
| 38 | ALK | 1.12422480 |
| 39 | BMPR2 | 1.11513944 |
| 40 | MAP3K12 | 1.09904256 |
| 41 | PIM1 | 1.07392336 |
| 42 | JAK1 | 1.05090710 |
| 43 | SIK2 | 1.03151249 |
| 44 | NEK2 | 1.02286055 |
| 45 | TGFBR2 | 0.96407738 |
| 46 | TAOK1 | 0.95523195 |
| 47 | CSF1R | 0.94523326 |
| 48 | PKN2 | 0.90881297 |
| 49 | PRKG2 | 0.90786359 |
| 50 | GRK7 | 0.89781198 |
| 51 | PRKD2 | 0.89113176 |
| 52 | TESK1 | 0.88341009 |
| 53 | LYN | 0.87975856 |
| 54 | FLT3 | 0.86767313 |
| 55 | MAPK4 | 0.85255849 |
| 56 | JAK2 | 0.84190622 |
| 57 | SIK3 | 0.83730970 |
| 58 | CAMK1D | 0.83355048 |
| 59 | TBK1 | 0.82884520 |
| 60 | LCK | 0.82354541 |
| 61 | STK4 | 0.81269104 |
| 62 | CAMK1G | 0.80368145 |
| 63 | KIT | 0.79733771 |
| 64 | MARK2 | 0.79400918 |
| 65 | MARK3 | 0.79267978 |
| 66 | MAPK12 | 0.77959825 |
| 67 | TNK2 | 0.77901384 |
| 68 | IRAK1 | 0.77357039 |
| 69 | MAP3K8 | 0.77242590 |
| 70 | IKBKE | 0.76674142 |
| 71 | PRKCQ | 0.74254522 |
| 72 | MAP2K6 | 0.72715158 |
| 73 | KDR | 0.71569084 |
| 74 | MAP3K3 | 0.70906034 |
| 75 | DMPK | 0.70752698 |
| 76 | FGFR3 | 0.70726748 |
| 77 | JAK3 | 0.66924736 |
| 78 | MAP2K4 | 0.66047480 |
| 79 | PTK2 | 0.65575718 |
| 80 | MAPK7 | 0.65001119 |
| 81 | MAP3K11 | 0.64976380 |
| 82 | DAPK2 | 0.64671419 |
| 83 | MAP3K13 | 0.62233064 |
| 84 | MAP3K7 | 0.61852301 |
| 85 | EEF2K | 0.59209363 |
| 86 | IRAK2 | 0.57195472 |
| 87 | MAP2K2 | 0.56297461 |
| 88 | PTK2B | 0.56261049 |
| 89 | RPS6KA6 | 0.55386180 |
| 90 | RIPK1 | 0.55282244 |
| 91 | RPS6KL1 | 0.55035297 |
| 92 | RPS6KC1 | 0.55035297 |
| 93 | HIPK2 | 0.54812570 |
| 94 | MATK | 0.51951011 |
| 95 | RPS6KA2 | 0.51040592 |
| 96 | FRK | 0.50475557 |
| 97 | YES1 | 0.49412557 |
| 98 | FYN | 0.49407377 |
| 99 | MAPKAPK2 | 0.48747129 |
| 100 | KSR2 | 0.48485664 |
| 101 | PIK3CG | 0.47835858 |
| 102 | TAOK2 | 0.46961353 |
| 103 | SGK3 | 0.45168962 |
| 104 | CDK4 | 0.44675580 |
| 105 | CDK6 | 0.44585049 |
| 106 | MAP3K6 | 0.43905638 |
| 107 | IKBKB | 0.43702623 |
| 108 | CDC7 | 0.42398366 |
| 109 | PRKCD | 0.41759729 |
| 110 | MAPK11 | 0.41563967 |
| 111 | STK11 | 0.40630813 |
| 112 | EPHA3 | 0.40214465 |
| 113 | DYRK1B | 0.39708264 |
| 114 | ABL1 | 0.39185060 |
| 115 | PDPK1 | 0.38793614 |
| 116 | MOS | 0.38673900 |
| 117 | PRKCH | 0.37889343 |
| 118 | MAP3K1 | 0.37847245 |
| 119 | PRKAA2 | 0.37636214 |
| 120 | STK24 | 0.37358809 |
| 121 | ADRBK2 | 0.36649453 |
| 122 | PDK1 | 0.36144185 |
| 123 | CDK7 | 0.35919686 |
| 124 | MAP3K5 | 0.35615620 |
| 125 | MAP4K2 | 0.33677374 |
| 126 | CAMKK2 | 0.33043122 |
| 127 | ADRBK1 | 0.31956855 |
| 128 | TLK1 | 0.28250860 |
| 129 | PINK1 | 0.27464124 |
| 130 | RPS6KA1 | 0.24729540 |
| 131 | MAPK3 | 0.23761392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.93509165 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.00414316 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.88269469 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.81146250 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.74289514 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.74029347 |
| 7 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.66910616 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.56488156 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.43896240 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.26273352 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21406999 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.18464824 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.96643615 |
| 14 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.91777277 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.89877979 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.88399480 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.82100313 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77000801 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.74175138 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74006276 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.72162783 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.67264561 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66739917 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57798366 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.56608343 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47849475 |
| 27 | Platelet activation_Homo sapiens_hsa04611 | 1.46374446 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44337928 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39930091 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39090668 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38432100 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.37184383 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.35721677 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.34859500 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.32887594 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31930175 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.27533364 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.25953522 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24651700 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.24603822 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.23219544 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18595061 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18501529 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18032478 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16032385 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.13187468 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12236049 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 1.12083747 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.11751935 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04638444 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03831503 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.02947808 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02153567 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01397094 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 1.01251032 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00992553 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.97929408 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97441367 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97427471 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95829872 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95323791 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.93636069 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88136286 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87123622 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86698853 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85794384 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.85017002 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82226656 |
| 69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79121578 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75871799 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74875689 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71230892 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.69394469 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69259632 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67291904 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67122790 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.66880797 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.64822776 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64242256 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64212686 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.62108287 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61599551 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60136598 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59626860 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59399541 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.58862720 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58838586 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57686571 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54902106 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54426566 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54127329 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54095134 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53777824 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52151844 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.51936545 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51394624 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50434200 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50002924 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49781515 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49089020 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48703530 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.47470373 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47032353 |
| 104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47002830 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45163267 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45129916 |
| 107 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44461219 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44191508 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43604540 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42893995 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41662450 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41396524 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40353882 |
| 114 | Focal adhesion_Homo sapiens_hsa04510 | 0.40245008 |
| 115 | DNA replication_Homo sapiens_hsa03030 | 0.38992277 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38912027 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38379805 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38313009 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37203770 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36912510 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35947322 |
| 122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34560909 |
| 123 | Cell cycle_Homo sapiens_hsa04110 | 0.34438208 |
| 124 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34356033 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33733974 |
| 126 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27499524 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23478787 |
| 128 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23261043 |

